The influence of cystathionine on neurochemical quantification in brain tumor in vivo MR spectroscopy

Authors:

Abstract
Purpose: To evaluate the ability of the PRESS sequence (TE = 97 ms, optimized for 2‐hydroxyglutarate detection) to detect cystathionine in gliomas and the effect of the omission of cystathionine on the quantification of the full neurochemical profile.Methods: Twenty‐three subjects with a glioma were retrospectively included based on the availability of both MEGA‐PRESS and PRESS acquisitions at 3T, and the presence of the cystathionine signal in the edited MR spectrum. In eight subjects, the PRESS acquisition was performed also in normal tissue. Metabolite quantification was performed using LCModel and simulated basis sets. The LCModel analysis for the PRESS data was performed with and without cystathionine.Results: All subjects with glioma had detectable cystathionine levels >1 mM with Cramér‐Rao lower bounds (CRLB) r = 0.58, p = .004), and it was not detectable in normal tissue. Using PRESS, 19 metabolites were quantified with CRLB p < .0028) and mostly affected by the omission of cystathionine were aspartate, betaine, citrate, γ‐aminobutyric acid (GABA), and serine.Conclusions: Cystathionine was detectable by PRESS in all the selected gliomas, while it was not detectable in normal tissue. The omission from the spectral analysis of cystathionine led to severe biases in the quantification of other neurochemicals that may play key roles in cancer metabolism.
Funding Information
  • Agence Nationale de la Recherche (ANR‐10‐IAIHU‐06, ANR‐11‐INBS‐0006, ANR‐20‐CE17‐0002‐01)
  • National Institutes of Health (P30 NS076408, P41 EB015894)

This publication has 36 references indexed in Scilit: